These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors. Chow L; De Gasparo M; Levens N Eur J Pharmacol; 1995 Aug; 282(1-3):77-86. PubMed ID: 7498292 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570). Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998 [TBL] [Abstract][Full Text] [Related]
12. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid. Johnson AL; Price WA; Wong PC; Vavala RF; Stump JM J Med Chem; 1985 Nov; 28(11):1596-602. PubMed ID: 2999393 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibitors: spirapril and related compounds. Smith EM; Swiss GF; Neustadt BR; McNamara P; Gold EH; Sybertz EJ; Baum T J Med Chem; 1989 Jul; 32(7):1600-6. PubMed ID: 2544729 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure. Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162 [TBL] [Abstract][Full Text] [Related]
17. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats. Battistini B; Ayach B; Molez S; Blouin A; Jeng AY Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123 [TBL] [Abstract][Full Text] [Related]